Development and Optimization of Glipizide Nanoliposomes for Enhanced Oral Delivery

Authors

https://doi.org/10.48314/nna.vi.62

Abstract

Glipizide is a sulfonylurea drug widely prescribed for the management of type II diabetes; however, its therapeutic efficiency is limited by significant degradation in the acidic gastric environment, resulting in reduced bioavailability. To address this limitation, glipizide-loaded nanoliposomes were prepared using the thin-film hydration method. A time-variant optimization strategy was applied to evaluate the influence of formulation parameters, including the lecithin-to-cholesterol ratio, the organic-to-aqueous solvent ratio, and the duration of liposome formation. The optimized values for these parameters were determined to be 7:1, 4:1, and 2 hours and 20 minutes, respectively, yielding an Encapsulation Efficiency (EE) of 90.12%. Particle size and morphology were examined using Scanning Electron Microscopy (SEM). The resulting nanoliposomes exhibited a uniform spherical shape with particle diameters ranging from 50 to 95 nm and a mean size of approximately 82 nm, indicating successful formation of nanoscale vesicles suitable for drug delivery applications. The nanosized structure is expected to enhance mucosal interaction and improve intestinal transport. Stability assessments performed at physiological pH (7.4) demonstrated a marked increase in the structural and chemical stability of glipizide following encapsulation. This improvement highlights the liposomal membrane's protective role against premature degradation in the gastrointestinal environment. Overall, the findings suggest that liposomal encapsulation provides an effective strategy to enhance the stability and potential oral bioavailability of glipizide. The optimized nanocarrier system developed in this study represents a promising platform for the controlled delivery of hydrophilic antidiabetic agents. It may contribute to improved therapeutic outcomes in future pharmaceutical formulations.

Keywords:

Diabetes type II, Glipizide, Encapsulation percentage, Nanoliposome

References

  1. [1] Roeini, M. R., Sadray, S., Hosseinzadeh Ardakani, Y., Mokhbari, M., & Sedaghat, S. (2006). Pharmacokinetic and pharmacodynamic evaluation of 500 mg metformin hydrochloride tablets in healthy volunteers. Iranian journal of diabetes and metabolism, 6(2), 135-141. (In Persian). https://sid.ir/paper/437714/fa
  2. [2] Baladi Mousavi, S. S., Layeq, P., Zeraati, A. A., & Tamadon, M. R. (2014). Diabetes and its treatment in patients with chronic kidney failure. Journal of the faculty of medicine, mashhad university of medical sciences, 57(7), 866–873. (In Persian). https://doi.org/10.22038/mjms.2014.3591
  3. [3] Yusaf, R., Nawaz, R., Hayat, S., Khursheed, A., Zafar, N., Ahmad, A., … & Majeed, I. (2014). Structural components of liposomes and characterization tools. American journal of pharm research, 4(8), 3559–3567. https://b2n.ir/fy3579
  4. [4] Keller, B. C. (2001). Liposomes in nutrition. Trends in food science & technology, 12(1), 25–31. https://doi.org/10.1016/S0924-2244(01)00044-9
  5. [5] Ghaedian, S., Ghaedian, Z., Sawti Khiabani, M., & Rezaei Makram, R. (2013). Encapsulation and its application in the food industry. 21st national congress of iranian food science and industry (pp. 1-6). Shiraz, Iran. Civilica.(In Persian). https://civilica.com/doc/235403
  6. [6] Manconi, M., Nácher, A., Merino, V., Merino-Sanjuan, M., Manca, M. L., Mura, C., … & Diez-Sales, O. (2013). Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. Aaps pharmscitech, 14(2), 485–496. https://doi.org/10.1208/s12249-013-9926-4
  7. [7] Banerjee, P., Deb, J., Roy, A., Ghosh, A., & Chakraborty, P. (2012). Fabrication and development of pectin microsphere of metformin hydrochloride. International scholarly research notices, 2012(1), 230621. https://doi.org/10.5402/2012/230621
  8. [8] Chang, M., Lu, S., Zhang, F., Zuo, T., Guan, Y., Wei, T., … & Lin, G. (2015). RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Colloids and surfaces b: Biointerfaces, 129, 175–182. https://doi.org/10.1016/j.colsurfb.2015.03.046
  9. [9] Tonegawa, J., Ohtuka, K., Nakano, M., & Shirotake, S. (2015). Reinforcement of antibiotic activity by nanoencapsulation of ampicillin against-lactamase producing and non-producing strains of methicillin-resistant Staphylococcus aureus. African journal of pharmacy and pharmacology, 9(7), 190–197. https://doi.org/10.5897/AJPP2013. 3487
  10. [10] Gültekin-Özgüven, M., Karadağ, A., Duman, Ş., Özkal, B., & Özçelik, B. (2016). Fortification of dark chocolate with spray dried black mulberry (Morus nigra) waste extract encapsulated in chitosan-coated liposomes and bioaccessability studies. Food chemistry, 201, 205-212. https://doi.org/10.1016/j.foodchem.2016.01.091
  11. [11] Kumar, R., Dogra, S., Amarji, B., Singh, B., Kumar, S., Vinay, K., … & Katare, O. P. (2016). Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: A randomized clinical trial. JAMA dermatology, 152(7), 807–815. https://doi.org/10.1001/jamadermatol.2016.0859
  12. [12] Tahover, E., Patil, Y. P., & Gabizon, A. A. (2015). Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: Focus on liposomes. Anti-cancer drugs, 26(3), 241–258. https://doi.org/10.1097/CAD.0000000000000182
  13. [13] Lu, Q., Lu, P. M., Piao, J. H., Xu, X. L., Chen, J., Zhu, L., & Jiang, J. G. (2014). Preparation and physicochemical characteristics of an allicin nanoliposome and its release behavior. LWT-food science and technology, 57(2), 686–695. https://doi.org/10.1016/j.lwt.2014.01.044
  14. [14] Motallebi Tala Tapeh, S., Sharifzadeh Baei, M., & Heidari Keshel, S. (2021). Synthesis of thermogel modified with biomaterials as carrier for hUSSCs differentiation into cardiac cells: Physicomechanical and biological assessment. Materials science and engineering: C, 119, 111517. https://doi.org/10.1016/j.msec.2020.111517
  15. [15] Hosseinzadeh, F., & Mehtarifar, H. (2025). Encapsulation of silymarin via Chitosan-PLGA nanoparticles for drug delivery. Biocompounds (biocompd.), 2(1), 42–52. https://doi.org/10.48313/bic.vi.32
  16. [16] Askarkiaee, S., & Sharifzadeh Baei, M. (2025). Preparation and swelling behaviour of Calcium-Alginate and Calcium Alginate-Chitosan Hydrogel Beads. Biocompounds, 2(1), 10–16. https://doi.org/10.48313/bic.vi.30
  17. [17] Marzban, A., Akbarzadeh, A., Ardestani, M. S., Ardestani, F., & Akbari, M. (2018). Synthesis of nano-niosomal deferoxamine and evaluation of its functional characteristics to apply as an iron-chelating agent. The canadian journal of chemical engineering, 96(1), 107–112. https://doi.org/10.1002/cjce.23048
  18. [18] Hoshani, M., Atabaki, R., Moghaddam, M. S., & Soleimani Moghaddam, M. (2025). The evaluation of antioxidant compounds of some medicinal plants and their effects on controlling gout disease. Biocompounds, 2(1), 1–9. https://doi.org/10.48313/bic.vi.29
  19. [19] Babakhani, B., Houshani, M., Motallebi Tala Tapeh, S., Nosratirad, R., Shoja Shafiee, M., & Heidari Keshel, S. (2019). The evaluation of antioxidant and anticancer activity of alfalfa extract on MCF7 cell line. Regeneration, reconstruction & restoration (triple r), 4(1), 9–14. https://doi.org/10.22037/rrr.v4i1.29646
  20. [20] Motallebi Tala Tapeh, S., Mahmoodi, N., & Vaziri, S. A. (2015). Synthesis of bis-chalcones based on 5, 5΄-methylenebis (2-hydroxybenzaldehyde) and screening their antibacterial activity. Journal of applied chemistry, 9(32), 53-58. https://doi.org/10.22075/chem.2017.681
  21. [21] Soleimani Moghaddam, M., Asadi Kafshgari, L., Houshani, M., Bahari, A., Sadeghi, B., Motallebi Tala Tapeh, S., & Shokraei, E. (2024). The role of Fe-Nx/N/V3C2 nanoelectrocatalyst based on organometallic framework in oxygen reduction activity. International journal of industrial chemistry, 15(4), 1-8. https://doi.org/10.57647/j.ijic.2024.1504.24
  22. [22] Motallebi Tala Tapeh, S., Mahmoodi, N. O., Ghanbari Pirbati, F., & Azimi, S. A. (2016). Saccharomyces cerevisiae as a biocatalyst for different carbonyl group under green condition. Organic chemistry research, 2(1), 39–42. https://doi.org/10.22036/org.chem..2016.13076
  23. [23] Motallebi Tala Tapeh, S., Mahmoodi, N., & Vaziri, S. A. (2015). Synthesis of bis-chalcones based on 5, 5΄-methylenebis (2-hydroxybenzaldehyde) and screening their antibacterial activity. Journal of applied chemistry, 9(32), 53-58. https://chemistry.semnan.ac.ir/article_681_a7d9047d3a417c52990be600b6defcf5.pdf
  24. [24] Lu, Q., Li, D. C., & Jiang, J. G. (2011). Preparation of a tea polyphenol nanoliposome system and its physicochemical properties. Journal of agricultural and food chemistry, 59(24), 13004–13011. https://doi.org/10.1021/jf203194w
  25. [25] Lu, X., Ross, C. F., Powers, J. R., Aston, D. E., & Rasco, B. A. (2011). Determination of total phenolic content and antioxidant activity of garlic (Allium sativum) and elephant garlic (Allium ampeloprasum) by attenuated total reflectance-fourier transformed infrared spectroscopy. Journal of agricultural and food chemistry, 59(10), 5215–5221. https://doi.org/10.1021/jf201254f
  26. [26] Akinoso, R., & Adeyanju, J. A. (2012). Optimization of edible oil extraction from ofada rice bran using response surface methodology. Food and bioprocess technology, 5(4), 1372–1378. https://doi.org/10.1007/s11947-010-0456-8
  27. [27] Myers, R. H., Montgomery, D. C., & Anderson-Cook, C. M. (2016). Response surface methodology: Process and product optimization using designed experiments. John Wiley & Sons. https://www.wiley-vch.de/en/areas-interest/mathematics-statistics/response-surface-methodology-978-1-118-91601-8
  28. [28] Niknejad, K., Sharifzadeh Baei, M., Motallebi Tala Tapeh, S. (2018). Synthesis of metformin hydrochloride nanoliposomes: Evaluation of physicochemical characteristics and release kinetics. International journal of nano dimension, 9(3), 298–313. (In Persian). https://www.sid.ir/paper/322408/en
  29. [29] Costa, P., & Lobo, J. M. S. (2001). Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13(2), 123–133. https://doi.org/10.1016/S0928-0987(01)00095-1
  30. [30] Jalababu, R., Veni, S. S., & Reddy, K. V. N. S. (2018). Synthesis and characterization of dual responsive sodium alginate-g-acryloyl phenylalanine-poly N-isopropyl acrylamide smart hydrogels for the controlled release of anticancer drug. Journal of drug delivery science and technology, 44, 190–204. https://doi.org/10.1016/j.jddst.2017.12.013
  31. [31] Sun, X. F., Zeng, Q., Wang, H., & Hao, Y. (2019). Preparation and swelling behavior of pH/temperature responsive semi-IPN hydrogel based on carboxymethyl xylan and poly (N-isopropyl acrylamide). Cellulose, 26(3), 1909–1922. https://doi.org/10.1007/s10570-018-2180-x
  32. [32] Hasan, A. A., Madkor, H., Wageh, SH. (2013). Formulation and evaluation of metformin hydrochloride loaded niosomes as a controlled release drug delivery system. Diabetes res. metab, 20(3–4), 120–126. https://doi.org/10.3109/10717544.2013.779332
  33. [33] Mahinroosta, M., Jomeh Farsangi, Z., Allahverdi, A., & Shakoori, Z. (2018). Hydrogels as intelligent materials: A brief review of synthesis, properties and applications. Materials today chemistry, 8, 42–55. https://doi.org/10.1016/j.mtchem.2018.02.004
  34. [34] Klouda, L. (2015). Thermoresponsive hydrogels in biomedical applications: A seven-year update. European journal of pharmaceutics and biopharmaceutics, 97, 338–349. https://doi.org/10.1016/j.ejpb.2015.05.017
  35. [35] Lebovitz, H. E. (2001). Oral therapies for diabetic hyperglycemia. Endocrinology and metabolism clinics, 30(4), 909–933. https://doi.org/10.1016/s0889-8529(05)70221-8
  36. [36] Sharma, H. K., Lahkar, S., & Nath, L. K. (2013). Formulation and in vitro evaluation of metformin hydrochloride loaded microspheres prepared with polysaccharide extracted from natural sources. Acta pharmaceutica, 63(2), 209–222. https://doi.org/10.2478/acph-2013-0019
  37. [37] Sharma, A., & Sharma, U. S. (1997). Liposomes in drug delivery: Progress and limitations. International journal of pharmaceutics, 154(2), 123–140. https://doi.org/10.1016/S0378-5173(97)00135-X
  38. [38] Thakur, N., Abhilash, C., Vivek, K., Nitan, B., & Neeraj, B. (2016). Liposome: Emerging trends in transdermal drug delivery. WJ pharmacy and pharmaceufical sciences, 5(5), 511–525. https://www.wjpps.com/Wjpps_controller/abstract_id/5063
  39. [39] Pezeshki Modaress, M., Mirzadeh, H., & Zandi, M. (2012). Fabrication of a porous wall and higher interconnectivity scaffold comprising gelatin/chitosan via combination of salt-leaching and lyophilization methods. Iranian polymer journal, 21(3), 191–200. https://doi.org/10.1007/s13726-012-0019-0

Downloads

Published

2026-03-27

Issue

Vol. 1 No. 1 (2026): Nano Nexus & Applications (NNA)

Section

Articles

How to Cite

Pourqasem, M. . (2026). Development and Optimization of Glipizide Nanoliposomes for Enhanced Oral Delivery. Nano Nexus & Applications, 1(1), 58-66. https://doi.org/10.48314/nna.vi.62